InsiderTrades

Form 4 for MRK Merck & Co.

Accepted 2026-05-01 18:54:19 ET · period of report 2026-04-29 · accession 0000310158-26-000102 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-05-01 18:54 2026-04-29 MRK Guindo Chirfi EVP, Access, Policy, Comms M - OptEx $110.03 +1,967 62.6K +3% +$216.4K
D 2026-05-01 18:54 2026-04-29 MRK Guindo Chirfi EVP, Access, Policy, Comms F - Tax $110.03 -969 61.6K -2% -$106.6K
D 2026-05-01 18:54 2026-04-29 MRK Guindo Chirfi EVP, Access, Policy, Comms M - OptEx $0.00 -1,967 3,935 -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-04-29 M A 1,967 $110.03 62,582.13 D — —
2 Common Common Stock 2026-04-29 F D 969 $110.03 61,613.13 D — —
3 Derivative Restricted Stock Unit 2026-04-29 M D 1,967 $0.00 3,935 D — · 2026-04-29 to 2028-04-29 1,967 Common Stock (F2) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F3) These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.